feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

YouTube and Google faced outages

trending

Colorado power shutoffs evaluated

trending

Disney characters in OpenAI videos

trending

Myanmar hit by magnitude 4.4 earthquake

trending

Fog warning in Himachal Pradesh

trending

Oklahoma Sooners beat Alabama

trending

Metro Detroit school closings Friday

trending

Slippery road conditions expected

trending

Seahawks win impacts standings

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Cancer Healed, Not Attacked: Novel Supplement Trial

Cancer Healed, Not Attacked: Novel Supplement Trial

19 Dec

•

Summary

  • Resveratrol and copper supplement combo weakened glioblastoma.
  • Tumor growth activity fell by 33% with no reported side effects.
  • Researchers caution study is experimental and needs replication.
Cancer Healed, Not Attacked: Novel Supplement Trial

Scientists in Mumbai, India, have investigated an experimental approach to treating glioblastoma, a particularly aggressive brain cancer. Their study, involving 20 patients, explored the potential of a simple and inexpensive combination of resveratrol and copper supplements.

The supplement mix, administered before surgery, demonstrated significant biological changes in tumor tissues. Key markers of tumor aggressiveness decreased, and inflammation-linked DNA fragments were nearly eradicated. Notably, tumor growth activity reportedly fell by approximately 33% without any adverse side effects observed in the treated patients.

While these initial results are encouraging, the research team stresses that the study is experimental and based on a small patient group. Larger, long-term trials are essential to validate these findings, ascertain the long-term safety of the supplements, and determine their actual impact on patient outcomes. They caution the public against self-medication, emphasizing the need for a controlled formulation and medical supervision.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Researchers found that a combination of resveratrol and copper supplements significantly weakened glioblastoma tumors in an experimental study.
No, the study is experimental and preliminary. Larger trials are needed to confirm safety and effectiveness; they are not a substitute for established treatments.
Dr. Mittra suggested that inexpensive nutraceutical tablets could potentially heal glioblastoma and that it's time to consider healing tumors rather than just annihilating them.

Read more news on

Indiaside-arrowHealthside-arrowMumbaiside-arrow

You may also like

Alcohol's Cancer Link: New Study Shifts Focus

16 Dec • 25 reads

article image

Desmoid Tumor Drug Shows Promise

16 Dec • 24 reads

article image

Roche Drug Slashes Breast Cancer Recurrence by 30%

10 Dec • 102 reads

article image

Mouth Ulcers: Women's Hidden Cancer Warning

6 Dec • 70 reads

article image

Young Adults Face Cancer Spread Risk

28 Nov • 117 reads

article image